Protein Kinase Inhibitors

Mark A Lemmon, PhD, FRS
Alfred Gilman Professor of Pharmacology; Deputy Director, Yale Cancer Center; Co-director, Cancer Biology Institute
Research Interests
Adenocarcinoma
Biochemistry
Cell Membrane
Crystallography
Protein-Tyrosine Kinases
Receptor Aggregation
Signal Transduction
Protein Structure, Tertiary
MAP Kinase Signaling System
Protein Kinase Inhibitors
ErbB Receptors
Single Molecule Imaging
Hydrogen Deuterium Exchange-Mass Spectrometry
View Full Profile